PTCT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.50%

Insider Buying (Last 12 Months): $198,737.00

Insider Selling (Last 12 Months): $1,787,917.16

PTC Therapeutics Insider Trading History Chart

PTC Therapeutics Share Price & Price History

^$33.95

▼ -0.04 (-0.12%)

As of 09/16/2024 04:08 PM ET

Days: 30 | 90 | 365

Ex-CIA Advisor: “This is How Kamala will Rig the Election”

From Paradigm Press | Ad

A former CIA advisor with close ties to the White House… Has just released this shocking expose on Kamala’s plan to stop Trump. Every American needs to prepare now…

Click here now and learn how to prepare.

PTC Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/16/2024	Pierre Gravier	CFO	Sell	2,269	$34.02	$77,191.38	53,531
5/22/2024	Jerome B Zeldis	Director	Sell	20,000	$38.24	$764,800.00	14,500
5/7/2024	Lee Scott Golden	EVP	Sell	175	$32.82	$5,743.50	59,813
4/19/2024	Matthew B. Klein	CEO	Sell	3,361	$24.89	$83,655.29	225,807
4/17/2024	Eric Pauwels	CEO	Sell	787	$25.14	$19,785.18	67,694
4/2/2024	Lee Scott Golden	EVP	Sell	526	$28.37	$14,922.62	59,988
1/30/2024	Christine Marie Utter	CAO	Sell	318	$27.25	$8,665.50	35,528
1/30/2024	Mark Elliott Boulding	VP	Sell	794	$27.25	$21,636.50	71,189
1/30/2024	Neil Gregory Almstead	Insider	Sell	618	$27.25	$16,840.50	61,202
1/22/2024	Allan Steven Jacobson	Director	Sell	10,000	$27.38	$273,800.00	12,348
1/8/2024	Christine Marie Utter	CAO	Sell	1,188	$28.64	$34,024.32	37,499
1/8/2024	Eric Pauwels	Insider	Sell	1,569	$28.64	$44,936.16	46,612
1/8/2024	Mark Elliott Boulding	VP	Sell	1,457	$28.64	$41,728.48	73,921
1/8/2024	Matthew B. Klein	CEO	Sell	2,237	$28.64	$64,067.68	165,918
1/8/2024	Michael Schmertzler	Director	Sell	1,500	$27.81	$41,715.00	115,266
1/5/2024	Matthew B. Klein	CEO	Sell	10,107	$27.15	$274,405.05	168,155
12/12/2023	Pierre Gravier	CFO	Buy	7,700	$25.81	$198,737.00	33,700
9/6/2023	Alethia Young	Director	Sell	11,666	$39.86	$465,006.76	9,067
5/11/2023	Allan Steven Jacobson	Director	Sell	23,000	$55.08	$1,266,840.00	12,348
4/21/2023	Christine Marie Utter	CAO	Sell	4,692	$55.06	$258,341.52	38,059
4/21/2023	Emma Reeve	Director	Sell	4,328	$55.05	$238,256.40	7,200
4/18/2023	Eric Pauwels	Insider	Sell	732	$52.04	$38,093.28	64,805
4/18/2023	Matthew B. Klein	CEO	Sell	1,211	$52.04	$63,020.44	102,645
4/17/2023	David P Southwell	Director	Sell	11,429	$51.03	$583,221.87	10,500
4/17/2023	Mark Elliott Boulding	VP	Sell	61,923	$51.42	$3,184,080.66	75,378
3/31/2023	David P Southwell	Director	Sell	2,571	$50.05	$128,678.55	10,500
3/29/2023	Christine Marie Utter	CAO	Sell	4,688	$47.79	$224,039.52	38,059
3/27/2023	Christine Marie Utter	CAO	Sell	26,658	$45.09	$1,202,009.22	38,059
3/27/2023	David P Southwell	Director	Sell	10,000	$45.10	$451,000.00	10,500
3/27/2023	Emily Luisa Hill	CFO	Sell	7,363	$45.00	$331,335.00	38,925
1/31/2023	Christine Marie Utter	CAO	Sell	325	$45.63	$14,829.75	38,059
1/31/2023	Emily Luisa Hill	CFO	Sell	575	$45.63	$26,237.25	46,288
1/31/2023	Eric Pauwels	Insider	Sell	375	$45.63	$17,111.25	65,537
1/31/2023	Mark Elliott Boulding	VP	Sell	812	$45.63	$37,051.56	75,378
1/31/2023	Stuart Walter Peltz	CEO	Sell	2,320	$45.63	$105,861.60	166,962
1/24/2023	Emily Luisa Hill	CFO	Sell	223	$47.45	$10,581.35	46,863
1/24/2023	Eric Pauwels	Insider	Sell	359	$47.45	$17,034.55	65,912
1/24/2023	Stuart Walter Peltz	CEO	Sell	284	$47.45	$13,475.80	55,204
1/11/2023	Christine Marie Utter	CAO	Sell	417	$44.36	$18,498.12	38,384
1/11/2023	Emily Luisa Hill	CFO	Sell	418	$44.36	$18,542.48	47,086
1/11/2023	Mark Elliott Boulding	VP	Sell	495	$44.36	$21,958.20	76,190
1/11/2023	Matthew B. Klein	COO	Sell	2,244	$44.36	$99,543.84	77,856
1/11/2023	Neil Gregory Almstead	Insider	Sell	383	$44.36	$16,989.88	64,579
1/11/2023	Stuart Walter Peltz	CEO	Sell	1,189	$44.36	$52,744.04	169,282
1/9/2023	Christine Marie Utter	CAO	Sell	706	$41.66	$29,411.96	39,290
1/9/2023	Emily Luisa Hill	CFO	Sell	758	$41.66	$31,578.28	48,001
1/9/2023	Mark Elliott Boulding	VP	Sell	835	$41.66	$34,786.10	77,275
1/9/2023	Matthew B. Klein	COO	Sell	731	$41.66	$30,453.46	82,373
1/9/2023	Neil Gregory Almstead	Insider	Sell	716	$41.66	$29,828.56	65,435
1/9/2023	Stuart Walter Peltz	CEO	Sell	1,786	$41.66	$74,404.76	171,699
10/18/2022	Mark Elliott Boulding	VP	Sell	299	$55.06	$16,462.94	61,110
9/20/2022	Mark Elliott Boulding	VP	Sell	1,176	$55.00	$64,680.00	61,110
8/9/2022	Stephanie S. Okey	Director	Sell	2,296	$51.62	$118,519.52	1,867
6/7/2022	Stuart Walter Peltz	CEO	Sell	407	$26.83	$10,919.81	38,239
4/19/2022	Eric Pauwels	Insider	Sell	822	$42.52	$34,951.44	49,772
4/19/2022	Matthew B. Klein	COO	Sell	897	$42.52	$38,140.44	56,564
4/14/2022	Stuart Walter Peltz	CEO	Sell	82	$45.28	$3,712.96	38,646
4/13/2022	Mark Elliott Boulding	VP	Sell	2,276	$45.17	$102,806.92	61,110
4/5/2022	Mark Elliott Boulding	VP	Sell	5	$45.00	$225.00	61,110
3/31/2022	Emily Luisa Hill	CFO	Sell	7,910	$37.78	$298,839.80
2/10/2022	Mark Elliott Boulding	VP	Sell	17,935	$45.03	$807,613.05
2/1/2022	Christine Marie Utter	CAO	Sell	313	$40.00	$12,520.00
2/1/2022	Emily Luisa Hill	CFO	Sell	553	$40.00	$22,120.00
2/1/2022	Eric Pauwels	Insider	Sell	367	$40.00	$14,680.00
2/1/2022	Mark Elliott Boulding	VP	Sell	779	$40.00	$31,160.00
2/1/2022	Stuart Walter Peltz	CEO	Sell	1,961	$40.00	$78,440.00
1/25/2022	Emily Luisa Hill	CFO	Sell	211	$39.31	$8,294.41
1/25/2022	Eric Pauwels	Insider	Sell	359	$39.31	$14,112.29
1/25/2022	Stuart Walter Peltz	CEO	Sell	330	$39.31	$12,972.30
1/18/2022	Christine Marie Utter	CAO	Sell	11,428	$43.94	$502,146.32
1/7/2022	Christine Marie Utter	CAO	Sell	747	$38.52	$28,774.44
1/7/2022	Emily Luisa Hill	CFO	Sell	800	$38.52	$30,816.00
1/7/2022	Mark Elliott Boulding	VP	Sell	885	$38.52	$34,090.20
1/7/2022	Neil Gregory Almstead	Insider	Sell	756	$38.52	$29,121.12
1/4/2022	Emily Luisa Hill	CFO	Sell	173	$41.16	$7,120.68
1/4/2022	Neil Gregory Almstead	Insider	Sell	64	$41.16	$2,634.24
1/4/2022	Stuart Walter Peltz	CEO	Sell	378	$41.16	$15,558.48

Protect Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

SEC Filings (Institutional Ownership Changes) for PTC Therapeutics (NASDAQ:PTCT)

Institutional Buying and Selling by Quarter

PTC Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/16/2024	Quarry LP	5,000	$0.15M	0.0%	+100.0%	0.007%
8/16/2024	Creative Planning	10,128	$0.31M	0.0%	+19.0%	0.013%
8/16/2024	Algert Global LLC	28,309	$0.87M	0.0%	N/A	0.037%
8/15/2024	Susquehanna Portfolio Strategies LLC	25,875	$0.79M	0.0%	-13.5%	0.034%
8/15/2024	Mackenzie Financial Corp	9,369	$0.29M	0.0%	N/A	0.012%
8/15/2024	The Manufacturers Life Insurance Company	43,796	$1.34M	0.0%	+6.5%	0.057%
8/15/2024	Millennium Management LLC	317,579	$9.71M	0.0%	+123.2%	0.413%
8/15/2024	AQR Capital Management LLC	68,912	$2.11M	0.0%	+307.9%	0.090%
8/15/2024	Armistice Capital LLC	6,962,227	$212.91M	2.7%	+2.9%	9.051%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	10,971	$0.34M	0.1%	N/A	0.014%
8/15/2024	Point72 Hong Kong Ltd	57,530	$1.76M	0.1%	+523.8%	0.075%
8/14/2024	Squarepoint Ops LLC	122,890	$3.76M	0.0%	N/A	0.160%
8/14/2024	Cubist Systematic Strategies LLC	478,441	$14.63M	0.1%	+33.9%	0.622%
8/14/2024	Marshall Wace LLP	179,679	$5.50M	0.0%	+708.7%	0.234%
8/14/2024	Bank of Montreal Can	54,982	$1.68M	0.0%	N/A	0.072%
8/14/2024	ProShare Advisors LLC	14,387	$0.44M	0.0%	-21.4%	0.019%
8/14/2024	Profund Advisors LLC	19,358	$0.59M	0.0%	-58.0%	0.025%
8/13/2024	Ensign Peak Advisors Inc	208,302	$6.37M	0.0%	+650.9%	0.272%
8/13/2024	Public Employees Retirement Association of Colorado	8,727	$0.27M	0.0%	-5.1%	0.011%
8/12/2024	Inspire Investing LLC	11,545	$0.35M	0.0%	-5.5%	0.015%
8/12/2024	XTX Topco Ltd	30,971	$0.95M	0.1%	N/A	0.040%
8/12/2024	Seven Eight Capital LP	18,415	$0.56M	0.1%	-68.6%	0.024%
8/12/2024	Hsbc Holdings PLC	18,918	$0.57M	0.0%	-18.5%	0.025%
8/9/2024	Edgestream Partners L.P.	22,080	$0.68M	0.0%	-58.7%	0.029%
8/9/2024	Renaissance Technologies LLC	818,100	$25.02M	0.0%	+7.4%	1.067%
8/8/2024	DekaBank Deutsche Girozentrale	29,016	$0.89M	0.0%	+20.9%	0.038%
8/8/2024	American Century Companies Inc.	37,394	$1.14M	0.0%	+108.7%	0.049%
8/8/2024	State of New Jersey Common Pension Fund D	53,093	$1.62M	0.0%	-46.8%	0.069%
8/8/2024	VitalStone Financial LLC	9,367	$0.29M	0.2%	N/A	0.012%
8/7/2024	Headlands Technologies LLC	6,611	$0.20M	0.0%	+83.2%	0.009%
8/7/2024	Cowen AND Company LLC	3,756,469	$114.87M	3.2%	+0.8%	4.898%
8/7/2024	Choreo LLC	11,426	$0.36M	0.0%	+4.1%	0.015%
8/6/2024	Quest Partners LLC	4,188	$0.13M	0.0%	N/A	0.005%
8/5/2024	Arizona State Retirement System	19,301	$0.59M	0.0%	+3.4%	0.025%
8/1/2024	Rhumbline Advisers	116,396	$3.56M	0.0%	+6.7%	0.152%
8/1/2024	LGL Partners LLC	12,000	$0.37M	0.1%	N/A	0.016%
7/30/2024	Pinnacle Associates Ltd.	153,904	$4.71M	0.1%	-1.9%	0.201%
7/30/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	445,515	$13.62M	0.0%	+1.4%	0.581%
7/29/2024	Principal Financial Group Inc.	12,322	$0.38M	0.0%	-30.6%	0.016%
7/29/2024	Panagora Asset Management Inc.	315,100	$9.64M	0.0%	+9.1%	0.411%
7/26/2024	Allspring Global Investments Holdings LLC	1,007	$31K	0.0%	-36.0%	0.001%
7/26/2024	Bank of New York Mellon Corp	279,049	$8.53M	0.0%	+17.1%	0.364%
7/22/2024	Sanibel Captiva Trust Company Inc.	6,700	$0.21M	0.0%	N/A	0.009%
7/20/2024	Neo Ivy Capital Management	40,708	$1.25M	0.2%	N/A	0.053%
7/18/2024	Assenagon Asset Management S.A.	372,827	$11.40M	0.0%	+21.7%	0.486%
7/16/2024	Diversified Trust Co	15,317	$0.47M	0.0%	+5.6%	0.020%
7/9/2024	Harbor Capital Advisors Inc.	47,380	$1.45M	0.1%	+39.1%	0.062%
5/22/2024	Burney Co.	42,040	$1.22M	0.0%	N/A	0.055%
5/16/2024	California State Teachers Retirement System	68,333	$1.99M	0.0%	-5.5%	0.089%
5/16/2024	Jacobs Levy Equity Management Inc.	1,605,841	$46.71M	0.2%	+21.3%	2.094%
5/16/2024	Janus Henderson Group PLC	3,669,816	$106.74M	0.1%	+40.5%	4.785%
5/15/2024	Public Employees Retirement System of Ohio	28,611	$0.83M	0.0%	-4.1%	0.037%
5/15/2024	Price T Rowe Associates Inc. MD	639,867	$18.61M	0.0%	-35.9%	0.834%
5/15/2024	Lazard Asset Management LLC	6,504	$0.19M	0.0%	+268.9%	0.008%
5/14/2024	EntryPoint Capital LLC	2,261	$66K	0.1%	-60.1%	0.003%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	113,500	$3.30M	0.0%	N/A	0.148%
5/14/2024	CANADA LIFE ASSURANCE Co	26,365	$0.77M	0.0%	-9.6%	0.034%
5/13/2024	Seven Eight Capital LP	58,692	$1.71M	0.2%	+148.3%	0.077%
5/11/2024	Edgestream Partners L.P.	53,522	$1.56M	0.1%	+49.3%	0.070%
5/10/2024	Vanguard Group Inc.	9,369,014	$272.55M	0.0%	+6.5%	12.216%
5/9/2024	State Board of Administration of Florida Retirement System	22,101	$0.64M	0.0%	+9.4%	0.029%
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	439,365	$12.78M	0.0%	+8.7%	0.573%
5/8/2024	ProShare Advisors LLC	18,313	$0.53M	0.0%	+9.3%	0.024%
5/8/2024	Russell Investments Group Ltd.	301,790	$8.78M	0.0%	+57.9%	0.393%
5/8/2024	Headlands Technologies LLC	3,609	$0.11M	0.0%	-23.0%	0.005%
5/8/2024	Inspire Investing LLC	12,214	$0.36M	0.0%	-13.0%	0.016%
5/7/2024	Susquehanna Portfolio Strategies LLC	29,900	$0.87M	0.0%	-62.8%	0.039%
5/7/2024	Empowered Funds LLC	41,598	$1.21M	0.0%	N/A	0.054%
5/6/2024	Duality Advisers LP	49,322	$1.44M	0.1%	+5.8%	0.064%
5/2/2024	Choreo LLC	10,974	$0.32M	0.0%	N/A	0.014%
5/1/2024	BNP Paribas Financial Markets	199,670	$5.81M	0.0%	-46.3%	0.260%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	41,691	$1.21M	0.0%	-8.9%	0.054%
4/30/2024	Allspring Global Investments Holdings LLC	1,574	$46K	0.0%	N/A	0.002%
4/29/2024	China Universal Asset Management Co. Ltd.	14,752	$0.43M	0.1%	+69.0%	0.019%
4/26/2024	Pinnacle Associates Ltd.	156,938	$4.57M	0.1%	+1.8%	0.205%
4/24/2024	Assenagon Asset Management S.A.	306,231	$8.91M	0.0%	+26.2%	0.400%
4/18/2024	Allspring Global Investments Holdings LLC	1,574	$46K	0.0%	N/A	0.002%
4/5/2024	Los Angeles Capital Management LLC	10,800	$0.31M	0.0%	+23.1%	0.014%
3/11/2024	Vanguard Group Inc.	8,800,843	$242.55M	0.0%	+10.8%	11.488%
3/5/2024	Fisher Asset Management LLC	95,778	$2.64M	0.0%	-6.2%	0.125%
3/5/2024	Wellington Management Group LLP	9,816,603	$270.55M	0.1%	+4.0%	12.814%
2/26/2024	Virtu Financial LLC	9,222	$0.25M	0.0%	-22.6%	0.012%
2/14/2024	Seven Eight Capital LP	23,637	$0.65M	0.1%	-63.5%	0.031%
2/14/2024	RTW Investments LP	7,423,970	$204.61M	3.2%	+2.6%	9.838%
2/13/2024	Armistice Capital LLC	6,864,000	$189.17M	2.6%	+11.6%	9.096%
2/13/2024	Rafferty Asset Management LLC	339,963	$9.37M	0.0%	+64.8%	0.451%
2/12/2024	TD Asset Management Inc	46,874	$1.29M	0.0%	-20.7%	0.062%
2/9/2024	Trexquant Investment LP	232,663	$6.41M	0.1%	N/A	0.308%
2/9/2024	UBS Group AG	288,748	$7.96M	0.0%	+270.8%	0.383%
2/9/2024	Norges Bank	546,375	$15.06M	0.0%	N/A	0.724%
2/8/2024	Panagora Asset Management Inc.	302,955	$8.35M	0.0%	-0.5%	0.401%
2/8/2024	Vise Technologies Inc.	12,808	$0.35M	0.1%	+20.1%	0.017%
2/7/2024	Jump Financial LLC	26,256	$0.72M	0.0%	+70.4%	0.035%
2/7/2024	BNP Paribas Financial Markets	371,580	$10.24M	0.0%	+263.3%	0.492%
2/7/2024	Teacher Retirement System of Texas	15,642	$0.43M	0.0%	-17.4%	0.021%
2/7/2024	E Fund Management Co. Ltd.	18,188	$0.50M	0.0%	+71.6%	0.024%
2/6/2024	Charles Schwab Investment Management Inc.	610,918	$16.84M	0.0%	+2.4%	0.810%
2/6/2024	Amalgamated Bank	9,492	$0.26M	0.0%	-7.0%	0.013%
2/6/2024	Los Angeles Capital Management LLC	8,776	$0.24M	0.0%	N/A	0.012%
2/6/2024	Swiss National Bank	133,565	$3.68M	0.0%	-9.0%	0.177%

Data available starting January 2016

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Today's Range

Now: $33.95

$33.58

$34.22

50 Day Range

MA: $33.10

$31.00

$35.53

52 Week Range

Now: $33.95

$17.53

$40.69

Volume

200,849 shs

Average Volume

856,926 shs

Market Capitalization

$2.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Who are the company insiders with the largest holdings of PTC Therapeutics?: PTC Therapeutics' top insider shareholders include:
Matthew B Klein (CEO)
Stuart Walter Peltz (CEO)
Michael Schmertzler (Director)
Matthew B Klein (COO)
Mark Elliott Boulding (VP)
Eric Pauwels (CEO)
Eric Pauwels (Insider)
Neil Gregory Almstead (Insider)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Emily Luisa Hill (CFO)
Christine Marie Utter (CAO)
Jerome B Zeldis (Director)
Allan Steven Jacobson (Director)
David P Southwell (Director)
Alethia Young (Director)
Emma Reeve (Director)
Learn More about top insider investors at PTC Therapeutics.
Who are the major institutional investors of PTC Therapeutics?: PTC Therapeutics' top institutional investors include:
Armistice Capital LLC — 9.05%
Cowen AND Company LLC — 4.90%
Renaissance Technologies LLC — 1.07%
Cubist Systematic Strategies LLC — 0.62%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 0.58%
Assenagon Asset Management S.A. — 0.49%
Learn More about top institutional investors of PTC Therapeutics stock.
Which major investors are selling PTC Therapeutics stock?: During the previous quarter, PTCT stock was sold by these institutional investors:
State of New Jersey Common Pension Fund D
Seven Eight Capital LP
Edgestream Partners L.P.
Profund Advisors LLC
Wolverine Asset Management LLC
Principal Financial Group Inc.
Hsbc Holdings PLC
Susquehanna Portfolio Strategies LLC
Within the previous year, company insiders that have sold PTC Therapeutics company stock include:
Matthew B Klein (CEO)
Stuart Walter Peltz (CEO)
Michael Schmertzler (Director)
Matthew B Klein (COO)
Mark Elliott Boulding (VP)
Eric Pauwels (CEO)
Eric Pauwels (Insider)
Neil Gregory Almstead (Insider)
Lee Scott Golden (EVP)
Pierre Gravier (CFO)
Emily Luisa Hill (CFO)
Learn More investors selling PTC Therapeutics stock.
Which major investors are buying PTC Therapeutics stock?: Within the previous quarter, PTCT stock was bought by institutional investors including:
Armistice Capital LLC
Ensign Peak Advisors Inc
Millennium Management LLC
Marshall Wace LLP
Squarepoint Ops LLC
Cubist Systematic Strategies LLC
Point72 Asset Management L.P.
Assenagon Asset Management S.A.